Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Healthcare Biotechnology
Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP... see more

TSXV:HEM - Post Discussion

Hemostemix Inc > NEWS
View:
Post by angeloet on Feb 24, 2022 2:33pm

NEWS

apparently Delaware case will be completed sometime very very soon, before the Florida case, so sometime towards the end of this month, maybe early next. This is great news !!!

 

has anyone been following the other case, can you give us an update. This is a sleeper, better start looking for a holiday home guys.

 

toes crossed

Comment by spectator51 on Feb 24, 2022 10:11pm
Why would you post this here doc and not on ceo?
Comment by WalterTheDawg on Feb 25, 2022 1:15am
This is Doc Holiday. Can't get into my old account so i started a new one. I'm not sure what Angelo heard but it sounds encouraging. I've been trying unsuccessfully to find info on Delaware but I've heard it's very much in motion and should be moving forward soon. We'll see I guess. A win there next quarter would be huge for us but this is all hopeful speculation so use ...more  
Comment by angeloet on Feb 25, 2022 11:34am
yes, info on the Delaware is non existent. but I'v been hearing that there is a date set for late Feb early March, likely not conclussory, but definately a step there. The Shapiro deal is MEGA. There was a piece on CRISPR providing the gene edditing for the transplant islets. That will be a total cure!!   This is a fukin gold mine. People are sleeping here. Granted, a little dicey ...more  
Hemostemix Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities